Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

In Silico Identification of Novel Aromatic Compounds as Potential HIV-1 Entry Inhibitors Mimicking Cellular Receptor CD4.

Andrianov AM, Nikolaev GI, Kornoushenko YV, Xu W, Jiang S, Tuzikov AV.

Viruses. 2019 Aug 13;11(8). pii: E746. doi: 10.3390/v11080746.

2.

Potential HIV-1 fusion inhibitors mimicking gp41-specific broadly neutralizing antibody 10E8: In silico discovery and prediction of antiviral potency.

Andrianov AM, Kashyn IA, Tuzikov AV.

J Bioinform Comput Biol. 2018 Apr;16(2):1840007. doi: 10.1142/S0219720018400073. Epub 2018 Jan 15.

PMID:
29439644
3.

Computational identification of novel entry inhibitor scaffolds mimicking primary receptor CD4 of HIV-1 gp120.

Andrianov AM, Kashyn IA, Tuzikov AV.

J Mol Model. 2017 Jan;23(1):18. doi: 10.1007/s00894-016-3189-4. Epub 2017 Jan 3.

PMID:
28050723
4.

Computational discovery of novel HIV-1 entry inhibitors based on potent and broad neutralizing antibody VRC01.

Andrianov AM, Kashyn IA, Tuzikov AV.

J Mol Graph Model. 2015 Sep;61:262-71. doi: 10.1016/j.jmgm.2015.08.003. Epub 2015 Aug 8.

PMID:
26298811
5.

In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.

Andrianov AM, Kornoushenko YV, Kashyn IA, Kisel MA, Tuzikov AV.

J Biomol Struct Dyn. 2015;33(5):1051-66. doi: 10.1080/07391102.2014.926832. Epub 2014 Jun 19.

PMID:
24942968
6.

Discovery of novel anti-HIV-1 agents based on a broadly neutralizing antibody against the envelope gp120 V3 loop: a computational study.

Andrianov AM, Kashyn IA, Tuzikov AV.

J Biomol Struct Dyn. 2014 Dec;32(12):1993-2004. doi: 10.1080/07391102.2013.848825. Epub 2013 Nov 20.

PMID:
24251545
7.

Hydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting cholesterol efflux by the ABCA1 transporter.

Sviridov DO, Andrianov AM, Anishchenko IV, Stonik JA, Amar MJ, Turner S, Remaley AT.

J Pharmacol Exp Ther. 2013 Jan;344(1):50-8. doi: 10.1124/jpet.112.198143. Epub 2012 Oct 5.

8.

Structural analysis of the envelope gp120 V3 loop for some HIV-1 variants circulating in the countries of Eastern Europe.

Andrianov AM, Kornoushenko YV, Anishchenko IV, Eremin VF, Tuzikov AV.

J Biomol Struct Dyn. 2013;31(7):665-83. doi: 10.1080/07391102.2012.706455. Epub 2012 Aug 13.

PMID:
22888999
9.

Discovery of novel promising targets for anti-AIDS drug developments by computer modeling: application to the HIV-1 gp120 V3 loop.

Andrianov AM, Anishchenko IV, Tuzikov AV.

J Chem Inf Model. 2011 Oct 24;51(10):2760-7. doi: 10.1021/ci200255t. Epub 2011 Sep 22.

PMID:
21888425
10.

Human immunodeficiency virus-1 gp120 V3 loop for anti-acquired immune deficiency syndrome drug discovery: computer-aided approaches to the problem solving.

Andrianov AM.

Expert Opin Drug Discov. 2011 Apr;6(4):419-35. doi: 10.1517/17460441.2011.560603. Epub 2011 Feb 26.

PMID:
22646019
11.
12.

Immunophilins and HIV-1 V3 loop for structure-based anti-AIDS drug design.

Andrianov AM.

J Biomol Struct Dyn. 2009 Feb;26(4):445-54.

PMID:
19108583
13.
14.
15.

3D structure model of the principal neutralizing epitope of Minnesota HIV-1 isolate.

Andrianov AM, Sokolov YA.

J Biomol Struct Dyn. 2004 Feb;21(4):577-90.

PMID:
14692801
16.

Structure and polymorphism of the principal neutralization site of Thailand HIV-1 isolate.

Andrianov AM, Sokalov YA.

J Biomol Struct Dyn. 2003 Feb;20(4):603-13.

PMID:
12529159
17.

Local structural properties of the V3 loop of Thailand HIV-1 isolate.

Andrianov AM.

J Biomol Struct Dyn. 2002 Jun;19(6):973-89.

PMID:
12023800

Supplemental Content

Loading ...
Support Center